Skip to main content
. 2022 Jan 4;22:3. doi: 10.1186/s12890-021-01741-x

Table 2.

Association of SNPs and haplotypes of OXSR1 with the number of exacerbations during the 1st year of follow up in non-smoker subjects

Locus No. of exacerbations, Mean ± SE (N) Codomiant Dominant Recessive
CC CR RR P* Pcorr P* Pcorr P* Pcorr
rs9839010 0.41 ± 0.03 (600) 0.28 ± 0.03 (308) 0.34 ± 0.11 (47) 0.038 0.383 0.011 0.114 0.268 1.000
rs61005484 0.38 ± 0.03 (845) 0.25 ± 0.06 (108) 0.5 ± 0.5 (2) 0.445 1.000 0.218 1.000 0.881 1.000
rs4955408 0.31 ± 0.04 (342) 0.44 ± 0.04 (462) 0.28 ± 0.05 (150) 0.081 0.811 0.090 0.905 0.411 1.000
rs1392283 0.39 ± 0.03 (758) 0.27 ± 0.04 (183) 0.15 ± 0.1 (13) 0.045 0.453 0.013 0.128 0.597 1.000
rs112221585 0.37 ± 0.03 (817) 0.33 ± 0.07 (131) 0.33 ± 0.33 (3) 0.846 1.000 0.566 1.000 0.875 1.000
rs74919163 0.31 ± 0.03 (481) 0.46 ± 0.04 (389) 0.21 ± 0.07 (66) 0.041 0.413 0.031 0.307 0.532 1.000
rs1384006 0.43 ± 0.04 (541) 0.28 ± 0.03 (356) 0.31 ± 0.09 (58) 0.015 0.153 0.004 0.039 0.476 1.000
rs156260 0.37 ± 0.03 (736) 0.36 ± 0.06 (206) 0 ± 0 (13) 0.635 1.000 0.928 1.000 0.344 1.000
rs9880223 0.38 ± 0.03 (845) 0.25 ± 0.06 (108) 0.5 ± 0.5 (2) 0.445 1.000 0.218 1.000 0.881 1.000
rs2298417 0.35 ± 0.03 (683) 0.4 ± 0.05 (247) 0.58 ± 0.15 (24) 0.120 1.000 0.131 1.000 0.080 0.802
rs2011 0.4 ± 0.03 (634) 0.3 ± 0.04 (284) 0.24 ± 0.09 (37) 0.067 0.673 0.020 0.201 0.490 1.000
Block1_ht1 0.34 ± 0.05 (216) 0.42 ± 0.04 (506) 0.28 ± 0.04 (233) 0.120 0.360 0.077 0.231 0.646 1.000
Block1_ht2 0.3 ± 0.06 (108) 0.44 ± 0.04 (435) 0.3 ± 0.03 (412) 0.029 0.087 0.025 0.075 0.513 1.000
Block2_ht2 0.47 ± 0.14 (34) 0.37 ± 0.05 (309) 0.36 ± 0.03 (612) 0.768 1.000 0.814 1.000 0.469 1.000

The italic, underlined P values indicate statistical significance (P < 0.05)

CC common allele homozygote, CR heterozygote, RR minor allele homozygote, SE standard error of mean, Pcorr corrected P value for multiple comparisons

Pcorr corrected P values using the effective number of independent marker loci (MeffLi) calculated by SNPSpD for each SNP (MeffLi = 10.03501), and using the number of haplotypes (n = 3) for each haplotypes

*Adjusted for age, sex, serum total IgE level, predicted FEV1% at the first visit, and total ICS and systemic steroid dose in the 1st year of visit as covariates